Artificial airway device

Information

  • Patent Grant
  • 9675772
  • Patent Number
    9,675,772
  • Date Filed
    Thursday, October 6, 2011
    13 years ago
  • Date Issued
    Tuesday, June 13, 2017
    7 years ago
Abstract
An artificial airway device to facilitate lung ventilation of a patient, having an airway tube, a gastric drain tube and a mask at one end of the airway tube, the mask including a backplate and having a peripheral formation capable of forming a seal around the circumference of the laryngeal inlet, the peripheral formation surrounding a hollow interior space or lumen of the mask and the airway tube opening into the lumen of the mask, wherein the mask includes an atrium for passage to the gastric drain tube of gastric matter leaving the esophagus is disclosed.
Description

This application is the U.S. National Phase under 35 U.S.C. §371 of International Application No. PCT/GB2011/001453, filed Oct. 6, 2011, which claims priority to Great Britain Patent Application No. 1017453.0, filed Oct. 15, 2010 and Great Britain Patent Application No. 1115456.4, filed Sep. 7, 2011.


BACKGROUND OF THE INVENTION

The present invention relates to an artificial airway device, and in particular to such a device which seeks to provide protection against gastric reflux.


For at least seventy years, endotracheal tubes comprising a long slender tube with an inflatable balloon disposed near the tube's distal end have been used for establishing airways in unconscious patients. In operation, the endotracheal tube's distal end is inserted through the mouth of the patient, into the patient's trachea. Once positioned, the balloon is inflated so as to form a seal with the interior lining of the trachea. After this seal is established, positive pressure may be applied to the tube's proximal end to ventilate the patient's lungs. Also, the seal between the balloon and the inner lining of the trachea protects the lungs from aspiration (e.g., the seal prevents material regurgitated from the stomach from being aspirated into the patient's lungs).


Although they have been successful, endotracheal tubes suffer from several major disadvantages. The principal disadvantage of the endotracheal tube relates to the difficulty of properly inserting the tube. Inserting an endotracheal tube into a patient is a procedure that requires a high degree of skill. Also, even for skilled practitioners, insertion of an endotracheal tube is sometimes difficult or not possible. In many instances, the difficulty of inserting endotracheal tubes has tragically led to the death of a patient because it was not possible to establish an airway in the patient with sufficient rapidity. Also, inserting an endotracheal tube normally requires manipulation of the patient's head and neck and further requires the patient's jaw to be forcibly opened widely. These necessary manipulations make it difficult, or undesirable, to insert an endotracheal tube into a patient who may be suffering from a neck injury.


The laryngeal mask airway device is a well known device that is useful for establishing airways in unconscious patients, and which seeks to address the above-described drawbacks associated with endotracheal tubes.


In contrast to the endotracheal tube, it is relatively easy to insert a laryngeal mask airway device into a patient and thereby establish an airway. Also, the laryngeal mask airway device is a “forgiving” device in that even if it is inserted improperly, it still tends to establish an airway. Accordingly, the laryngeal mask airway device is often thought of as a “life saving” device. Also, the laryngeal mask airway device may be inserted with only relatively minor manipulation of the patient's head, neck and jaw. Further, the laryngeal mask airway device provides ventilation of the patient's lungs without requiring contact with the sensitive inner lining of the trachea and the internal diameter of the airway tube is typically significantly larger than that of the endotracheal tube. Also, the laryngeal mask airway device does not interfere with coughing to the same extent as endotracheal tubes. Largely due to these advantages, the laryngeal mask airway device has enjoyed increasing popularity in recent years.


U.S. Pat. No. 4,509,514 describes a laryngeal mask airway device which consists of the basic parts which make up most if not all laryngeal mask airway devices, namely an airway tube opening at one end into the interior of a hollow mask portion shaped to fit readily behind the larynx of a patient. The periphery of the mask is formed by a cuff which in use forms a seal around the opening of the larynx. This enables the airway to be established effectively.


Laryngeal mask airway devices with specific provision for gastric-discharge drainage have been developed, as exemplified by U.S. Pat. No. 4,995,388 (FIGS. 7 to 10); U.S. Pat. No. 5,241,956; and U.S. Pat. No. 5,355,879. These devices generally incorporate a small-diameter drainage tube having an end located at the distal end of the mask, so as to lie against the upper end of the upper oesophageal sphincter when the mask is in place, the tube being of sufficient length to extend out of the mouth of the patient to enable active or passive removal of gastric discharge from the upper oesophageal sphincter. According to alternative proposals, the drainage tube may extend beyond the distal end of the mask, into the oesophagus itself (U.S. Pat. No. 4,995,388, FIGS. 7 and 11).


Such devices are generally useful in providing for extraction of regurgitated matter, but are still not always fully effective in preventing aspiration of gastric contents into the patient's lungs. In particular, where the gastric discharge is as a result of the patient vomiting, rather than merely from regurgitation of the gastric matter, the substantial pressure of the vomited matter may in certain cases be enough to dislodge the mask altogether, even where a drainage tube is provided, potentially affecting the integrity of the artificial airway and/or resulting in the vomited matter being aspirated into the lungs of the patient.


As will be appreciated, the potential for the mask to become dislodged under vomiting is also inherent in masks such as that disclosed by U.S. Pat. No. 4,509,514, which do not feature a drainage tube.


Particularly where a mask does not provide for gastric drainage, and even where a gastric drainage tube is provided, there is even a risk of a potentially fatal build up of pressure in the oesophagus if vomited matter cannot be effectively vented from the oesophagus, which might for example occur if the mask becomes jammed in the pharynx.


Previous laryngeal masks designed for example according to U.S. Pat. No. 4,995,388 (FIGS. 7 to 10); U.S. Pat. No. 5,241,956; and U.S. Pat. No. 5,355,879 provided channels to accept regurgitant fluids arising from the oesophagus in which the diameter of the channels is approximately constant and equivalent to the diameter of the constricted area of the anatomy known as the upper oesophageal sphincter. Such devices, once pressed against the sphinctral region provide conditions in which liquids arising from the oesophagus maintain approximately the same velocity as they pass through the tube of the device. Such devices, when correctly positioned, mimic the anatomy of the sphincter, but not that of the oesophagus, in which conditions of lower flow and therefore of higher pressure prevail during reflux of fluids. Such a position of the device may be undesirable however, because the principal object of such devices having a drainage tube communicating with the oesophageal opening is to avoid leakage of any gastric fluids arising from the oesophagus from leaking around the sides of the device, because such leakage risks contamination of the larynx by these fluids with consequent grave risk to the patient.


Furthermore, existing devices provided with gastric drainage tubes do not have tubes with a diameter as great as that of the oesophageal sphincter and therefore can only offer an increase in velocity of fluids entering the drainage tube, which as seen above results in a reduced pressure in the narrower tube, which will tend to cause fluids from the higher pressure region to force the distal end of the device away from the sphincter.


SUMMARY OF THE INVENTION

The present invention seeks to ameliorate problems associated with the prior-art described above.


According to the invention there is provided an artificial airway device to facilitate lung ventilation of a patient, comprising an airway tube, a gastric drain tube and a mask at one end of the at least one airway tube, the mask including a backplate and having a peripheral formation capable of forming a seal around the circumference of the laryngeal inlet, the peripheral formation surrounding a hollow interior space or lumen of the mask and the airway tube opening into the lumen of the mask, wherein the mask includes an atrium for passage to the gastric drain tube of gastric matter leaving the oesophagus. As will be appreciated, the atrium provides an enlarged space or conduit that potentially substantially reduces the risk of the mask becoming dislodged on the occurrence of regurgitation or vomiting of matter, allowing the integrity of the airway to be maintained, and thereby potentially greatly minimises the risk of gastric insuflation.


It is preferred that the atrium is defined by a part of the backplate, and in particular that the defining part is a wall of the backplate. This provides a compact construction that utilises existing mask structures to provide the gastric conduit. The wall may comprise an outer skin and an inner skin, the atrium being formed between the skins and the skins may be formed from a resiliently deformable material that is softer in durometer than the material of the airway tube to aid in insertion.


In a particularly preferred embodiment the outer skin comprises a part of the gastric drain tube and the inner skin comprises a part of the airway tube, which again utilises existing structures. The said part of the gastric drain tube may be an integrally formed part thereof, to assist in manufacture and the said part of the airway tube may include a bore in fluid communication with the lumen of the mask.


Conventionally in laryngeal mask construction the gastric drain is provided as a tube within the airway tube, chiefly because it has been felt to be most important to retain as large a bore as possible for passage of gasses whilst also providing a compact structure to fit within the anatomy. In the present instance it has been found unexpectedly that the airway tube can be disposed within the gastric drain tube without loss of performance as an airway, and with the added benefit that a larger gastric drain conduit, and even more than one gastric drain conduit can be provided. In one embodiment of the invention the airway tube may be disposed to establish a separation of the space within the gastric drain tube into two gastric conduits.


According to a second aspect of the invention there is provided an artificial airway device to facilitate lung ventilation of a patient, comprising an airway tube, a gastric drain tube and a mask at one end of the at least one airway tube, the mask including a backplate and having a peripheral formation capable of forming a seal around the circumference of the laryngeal inlet, the peripheral formation surrounding a hollow interior space or lumen of the mask and the airway tube opening into the lumen of the mask, the device being adapted to allow for a visual inspection of its contents when the device is removed form the patient. This may be achieved by the provision of a transparent or even translucent backplate outer wall skin. This enables a user to easily discover the cause of a blockage.


According to a third aspect of the invention there is provided an artificial airway device to facilitate lung ventilation of a patient, comprising an airway tube, a gastric drain tube and a mask at one end of the airway tube, the mask including a backplate, gastric drainage conduit and having a peripheral formation capable of forming a seal around the circumference of the laryngeal inlet, the peripheral formation surrounding a hollow interior space or lumen of the mask and the airway tube opening into the lumen of the mask, the gastric drainage conduit including an inlet, the mouth of the inlet being formed such that it is disposed substantially normal to the axis of the oesophageal sphincter of the patient when the device is in situ. This helps achieve a more effective seal with the oesophageal sphincter.


Thus the advantages of the above described arrangements include, for example, less complicated manufacturing than in prior structures that include tubes or tubular formations in the backplate. Furthermore, the stiffness of the backplate is reduced when compared to previous structures involving backplate tubes, thus aiding ease of insertion. Having the conduit provided by the backplate in this manner also provides a conduit of large and expandable volume such that displacement of the device under vomiting is less likely to occur, particularly where the outer skin, or both skins of the conduit are formed from a softly pliant resiliently deformable material.


The device may include a plurality of gastric drain tubes, each said tube being in fluid communication with the atrium. This allows for application of suction to one of the tubes, in use. It is particularly preferred that the device includes two drain tubes. Where only a single gastric drain tube has been used in prior devices it has been found that damage to delicate structures of the anatomy such as the oesophageal sphincter can occur when suction is applied. In the present design, the presence of a plurality of gastric drain tubes ensures that when suction is applied to one tube to remove gastric material in the atrium, the other gastric tube allows air to be drawn into the atrium rather than the patient's anatomy.


Where the device includes two gastric drain tubes it is preferred that the tubes are disposed in side by side relation with the airway tube therebetween, the drain tubes and airway tube together defining a pocket disposed to accommodate a patient's tongue when the device is in use. This makes the device more comfortable for the patient. Where the airway tube comprises (as is desirable) a more rigid material than the drain tubes, the airway tube thus provides support to the drain tubes that may remove the need for a biteblock, thus again simplifying manufacturing and saving cost.


In an alternative embodiment, the device may comprise a single gastric drain tube in fluid communication with the atrium. It is preferred that the drain tube comprises a softly pliant collapsible material. The drain tube may be disposed on a surface of the airway tube, or around the airway tube, for support.


It is preferred that the peripheral formation comprises an inflatable cuff, or a non-inflatable cuff. It is further preferred that where the peripheral formation comprises an inflatable cuff, the backplate overlies the cuff and is bonded to it, such that on deflation the cuff may be collapsed upon it, thereby encouraging the cuff to pack flat.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention will now further be described by way of example, with reference to the accompanying drawings, in which:



FIG. 1 is a ventral view of a device according to the invention;



FIG. 2 is a dorsal view of the device of FIG. 1;



FIG. 3 is a side view of the device of FIG. 1;



FIG. 4 is schematic transverse sectional view of a part of a device according to the invention;



FIG. 5 is a longitudinal sectional view of the device of FIG. 1;



FIG. 6 is an exploded view of the device of FIG. 1;



FIG. 7 is a dorsal view of an alternative embodiment of device according to the invention;



FIG. 8 is a dorsal three quarter perspective view of a further alternative embodiment of device according to the invention;



FIG. 9 is a longitudinal sectional view of the device of FIG. 8;



FIG. 10 is a longitudinal sectional view of the device of FIG. 8;



FIGS. 10a to 10f are transverse sectional views taken along lines 1 to 6 in FIG. 10;



FIG. 11 is an exploded view of the device of FIG. 8;



FIG. 12 is a front three quarter perspective view of a part of the device of FIG. 8;



FIG. 13 is a plan view of the part of FIG. 12;



FIG. 14 is a transverse sectional view along line X-X in FIG. 13;



FIG. 15 is a rear three quarter perspective view of the part of FIG. 12;



FIG. 16 is a rear end view of the part of FIG. 12;



FIG. 17 is a front perspective view of a part of the device of FIG. 8;



FIG. 18 is a side view of the part of FIG. 17;



FIG. 19 is an end view of the part of FIG. 17;



FIG. 20 is a plan view of a part of the device of FIG. 8;



FIG. 21 is a transverse sectional view along line Y-Y of FIG. 20;



FIG. 22 is a longitudinal view along line Z-Z of FIG. 20;



FIG. 23 is plan perspective view of the part of FIG. 20;



FIG. 24 is an underplan perspective view of the part of FIG. 20;



FIG. 25 is a front end view of the part of FIG. 20;



FIG. 26 is an underplan view of a part of the device of FIG. 8;



FIG. 27 is a longitudinal sectional view along line A-A in FIG. 26;



FIG. 28 is a transverse sectional view along line B-B in FIG. 26;



FIG. 29 is a front view of the part of FIG. 26;



FIG. 30 is a front perspective view of the part of FIG. 26;



FIG. 31 is a plan perspective view of the part of FIG. 26;



FIG. 32 is an underplan perspective view of the part of FIG. 26; and



FIG. 33 is a rear perspective view of the part of FIG. 26.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

In the discussion of the following exemplary embodiments, like parts will generally be given the same reference numerals throughout the description.


Referring to the drawings, there is illustrated an artificial airway device 1 to facilitate lung ventilation of a patient, comprising an airway tube 2, a gastric drain tube 3 and a mask 4 at one end of the airway tube 2, the mask 4 including a backplate 5 and having a peripheral formation 6 capable of forming a seal around the circumference of the laryngeal inlet, the peripheral formation 6 surrounding a hollow interior space 7 or lumen of the mask 4 and the at least one airway tube 2 opening into the lumen of the mask, wherein the mask includes an atrium 8 for passage to the gastric drain tube 3 of gastric matter leaving the oesophagus.


For convenience, the surface of the device illustrated in FIG. 1 is herein referred to as the dorsal surface and the surface of the device illustrated in FIG. 2, which is the opposite surface to that shown in FIG. 1, is referred to as the ventral surface. In accordance with standard practice, the part of the device 1 that in use will extend from the patient is referred to herein as the proximal end (in the sense that it is nearest the user) with the other end being referred to herein as the distal end.


Referring in particular to FIGS. 1 to 6, the device 1 as illustrated includes two gastric drain tubes 3 disposed on either side of airway tube 2 and bonded thereto. It is preferable that the drain tubes 3 are formed from a sufficiently soft resiliently deformable material to be collapsible so that insertion of the device is made easier and also that the space within the anatomy required to accommodate the device in situ is minimised. As an example, the material of the gastric drain tubes 3 is preferably of 20 to 30 Shore durometer. Airway tube 2 is formed from a more rigid material than the drain tubes 3 such that it is not collapsible and has a preformed fixed curve as illustrated in FIG. 3. As an example, the airway tube 2 may be of 80 Shore durometer. It is bonded to the drain tubes such that a portion 2a of its length protrudes dorsally thereabove. As will be appreciated, this forms a hollow or pocket 2b on the ventral side. The drain tubes and airway tube may be formed from any known suitable material.


At its distal end, airway tube 2 is attached to mask 4. Airway tube 2 and mask 4 may be formed integrally or separately. It will be noted, particularly from FIGS. 5 and 6, that airway tube 2 terminates towards the proximal end of mask 4 at 2c. Thus mask 4 does not suffer in terms of being made too rigid by the material of the airway tube. Mask 4 includes a backplate 5 that is formed integrally with drain tubes 3. One notable feature of the present invention is the construction of the backplate. As the skilled worker will appreciate, the term “backplate”, when used in the present technical field has come to denote that part of the mask that is surrounded by the cuff in the assembled device and which provides separation between the laryngeal and pharyngeal regions when the device is in situ in the patient. Supply of gas takes place through an aperture in the backplate via a fluid tight connection between the part of the backplate defining the aperture and the airway tube. In one known arrangement the backplate and airway tube are formed integrally which is a particularly convenient arrangement. In the prior art, backplates are generally bowl or dome shaped structures rather than flat structures and the term is therefore not entirely descriptive of the shape.


In the presently described embodiment backplate 5 comprises inner and outer skins 5a, 5b that together define a space therebetween, as shown schematically in FIG. 4. The space so defined is atrium 8 from which proximally, drain tubes 3 lead off and distally, inlet 8a enters (as shown in FIG. 2). Thus atrium 8 can be regarded as a manifold that connects the single gastric inlet 8a with the two gastric drain tubes 3. One method of constructing the mask 4 is illustrated in FIG. 6, from which it can be seen that the gastric drain tubes 3 and backplate 5 are integrally formed. It will be appreciated that in the illustrations the material from which the backplate 5 and drain tubes 3 are formed is transparent to aid in understanding of the construction of the device 1.


As mentioned above, mask 4 includes peripheral formation 6 which in this embodiment takes the form of an inflatable cuff of generally known form. Cuff 6 includes an inflation line 6a at its proximal end and has a gastric inlet aperture 6b at its distal end that communicates via a bore with an inner aperture 6c (FIG. 2). The bore is defined by a collapsible tube. Means may be provided to keep the tube collapsed until the cuff is inflated, such as a press-stud or “ziplock” arrangement. Referring to the exploded view in FIG. 6, it can be seen that the dorsal surface of Cuff 6 is bonded to backplate 5 so that the material of the dorsal surface of the cuff 6 forms a bridge between the inner and outer skins 5a, 5b thus closing off the ventral side of atrium 8 except where gastric inlet aperture 6b enters the cuff. Thus it can be seen that gastric inlet 6b is in fluid communication with atrium 8 via aperture 6c. In an alternative method of construction the cuff 6 may be formed with a web across its aperture that itself forms the ventral surface of atrium 8.


Referring now to FIG. 7, there is illustrated an alternative embodiment of device 1. In this embodiment the device includes a single gastric drain 3 in the form of a softly pliant sleeve that terminates at its distal end in atrium 8, all other features of construction being the same as in the first described embodiment hereinabove.


In use, the device 1 is inserted into a patient to establish an airway as with prior art devices. Insertion is effected to the point where gastric inlet aperture 6b meets the patient's oesophageal sphincter, thus establishing fluid communication therebetween. If vomiting or regurgitation occurs, as with previous gastric access laryngeal masks, the material from the oesophagus passes into gastric inlet aperture 6b. However, unlike with previous devices the material passes into the atrium 8 formed between the dual backplate skins 5a 5b, the volume of which is larger than the volume of the inlet aperture 6b. It will be appreciated that constructing a laryngeal mask with a backplate 5 in which is formed an atrium or conduit 8 for gastric material is a highly efficient and economical way to use existing mask structures. Forming gastric drain tubes from an expandable material so that the space they occupy in the anatomy is minimised until they are called upon to perform their function is advantageous because it makes insertion of the device easier and causes less trauma to the delicate structures of the anatomy when the device is in place, particularly if the device is left in place for an extended period. And still further advantages are obtained if these features are combined such that the atrium 8 is formed from the soft material of the gastric drain tubes makes because the mask, whilst being sufficiently soft to avoid trauma on insertion can yet provide a large volume atrium 8 that can expand under pressure of vomiting. Such expansion results in a dorsal deformation of the outer skin 5b resembling a dome (FIG. 4) that acts like a spring against the back wall of the throat when the mask is in situ, forcing the cuff 6 against the larynx and thereby helping to maintain the device in its sealed state.


Referring now to FIGS. 8 to 33, there is illustrated a further alternative embodiment of device 1 according to the invention. This embodiment differs from the previously described embodiment in a number of important respects as will be described. However it will be appreciated that the concepts which it embodies may be applied to the previously described embodiments and vice versa.


Referring in particular to FIGS. 8 and 9, there is illustrated an artificial airway device 1 to facilitate lung ventilation of a patient, comprising an airway tube 2, a gastric drain tube 3 and a mask 4 at one end of the airway tube 2, the mask 4 including a backplate 5 and having a peripheral formation 6 capable of forming a seal around the circumference of the laryngeal inlet, the peripheral formation 6 surrounding a hollow interior space 7 or lumen of the mask 4 and the at least one airway tube 2 opening into the lumen of the mask, wherein the mask includes an atrium 8 for passage to the gastric drain tube 3 of gastric matter leaving the oesophagus.


It can be seen that the device 1 resembles other laryngeal mask airway devices. However, from the exploded view of FIG. 11 it can be seen that the device 1 comprises three main parts, a gastric drain and airway tube and backplate combination part 100, an inner backplate wall 110, a peripheral formation 120, and two minor parts, an inlet ring 130 and a connector 140.


Referring now to FIGS. 26 to 33, the gastric drain and airway tube and backplate combination part 100 will be described. This combination part 100 consists of a precurved tube 101. The tube 101 is not circular in cross-section but has a flattened section, as taught in previous patents, for ease of insertion and fit through the interdental gap. The tube 101 has flattened dorsal and ventral surfaces 101a, 101b and curved side walls 101c extending from a proximal end 101d to a distal end 101e. Towards the proximal end 101d on the dorsal surface there is disposed a fixation tab 102 and at the end is attached a plate 102a (FIG. 33). Plate 102a includes three apertures, two gastric apertures 102b either side of an airway aperture through which an airway conduit 107 extends. At its distal end the combination part 100 is cut at an angle relative to its longitudinal axis to provide a flared outer backplate part 104 integrally formed therewith, for example by molding. As an alternative the flared backplate part 104 can be separately formed, in particular from a transparent or translucent material. The backplate part 104 includes a circumferential lip 104a. Finally, it will be noted that combination part 100 includes a substantially coaxially disposed inner tube extending from the distal end to the proximal end, the inner tube effectively establishing a separation of the inner space into two gastric conduits 106 and an airway conduit 107. It will be noted that unlike in prior art constructions, this results in an airway conduit 107 contained within a gastric drain conduit. In the longitudinal sectional view shown in FIG. 27 it can be seen that the airway conduit 107 terminates in a cylindrical connector extension 109 at its distal end. Referring now to FIGS. 20 to 25, there is illustrated inner backplate wall 110. Inner backplate wall 110 comprises a generally elliptical body in the form of a shallow dish including side wall 111 and floor 112. At the distal, or narrower end of the elliptical dish, side wall 111 has a cylindrical aperture 111a formed therein that extends distally generally in line with the midline of the floor 112. It will be noted that cylindrical aperture 111a is angled upwardly, relative to the plane of the floor 112 such that the angle of the axis of the bore of the cylindrical aperture is about 20 degrees relative thereto. Along its midline the floor 112 of the dish is raised to form a convex surface that extends longitudinally towards the wider, proximal end where it terminates in a cylindrical formation that may be referred to as a tube joint 113. Tube joint 113 includes bore 113a that provides a connecting passage between the upper and lower surfaces (as viewed) of floor 112. Tube joint 113 merges with and bisects side wall 111 and is angled upwardly at about 45 degrees relative to floor 112, terminating proximally some distance beyond the side wall 111 as shown in FIG. 24.


Referring now to FIGS. 12 to 16, there is illustrated peripheral formation 120 which in this embodiment takes the form of an inflatable cuff. It will be noted that unlike many other laryngeal mask airway devices the cuff 120 is formed integrally as a separate part from the rest of the device, making it easier both to manufacture and attach to the device 1. The cuff 120 comprises a generally elliptical body with a narrower distal end 120a, a wider proximal end 120b and a central elliptical through-aperture 120c. As such it will be appreciated that the cuff resembles a ring. As can be seen from the sectional view in FIG. 14, the elliptical body comprises a wall 123 that is generally circular in section at the distal end but deeper and irregularly shaped at the proximal end by virtue of an integrally formed extension 121 formed on the dorsal surface at the proximal end 120b. This dorsal surface extension 121 defines the proximal portion of an attachment surface 122 (FIGS. 11 and 12). The attachment surface 122 extends from the proximal end to the distal end around the entire dorsal inner circumference of the ring. At its distal end 120a the cuff has a cylindrical through bore 121 the axis of which extends in line with the midline of the ellipse and is angled upwardly as viewed in FIG. 14 relative to the plane of the body, in other words from the ventral towards the dorsal side or when the device 1 is in use from the laryngeal to the pharyngeal side of the anatomy (L and P in FIG. 14). The result is a circular section aperture through the cuff wall 123. The proximal end 120b of the cuff includes a port 124 that lets into the interior of the bore and the cuff.


Referring now to FIGS. 17 to 19 there is illustrated inlet ring 130. Inlet ring 130 is a cylindrical section tube having a proximal end 131 cut normal relative to the axis “J” of bore 132 of the tube. The distal end 133 is cut obliquely, relative to the axis “J” of the bore 132, the cut extending back from the ventral to the dorsal side as viewed. It will be seen that the obliquely cut distal end 132 has a shallow curve, rather than being a straight cut. The wall of the cylinder includes minor open through bores 134 that extend the length of the cylinder and are open at each end.



FIG. 11 illustrates how the parts of device 1 fit together and is most usefully viewed in combination with FIGS. 8 and 9. From these it can be seen that the combination part 100, and inner backplate wall 110 are combined to form the backplate 5, thus defining a conduit in the form of chamber or atrium 8 within the backplate 5. The peripheral part 120, in this embodiment an inflatable cuff, is attached to the backplate 5 by bonding to the attachment surface 122 such that the backplate 5 seats within it. The connector 130 is passed through the cylindrical bore 121 in the cuff wall and affixed therein in connection with the cylindrical aperture 111a.


As mentioned, the embodiment of FIGS. 8 to 33 differs from prior art devices in a number of important respects. For example, in this device the airway tube 107 is contained within the gastric drain tube whereas in prior art devices the opposite is the case. It has been found that contrary to expectation it is most important in a device having a gastric tube that flow of gastric material should not be impeded, so that the seal formed around the upper oesophageal sphincter is not broken. This arrangement best utilises the available space within the anatomy to achieve this end. Similarly, the provision of an atrium 8 to receive gastric flow as opposed to the simple uniform section conduits of prior devices provides a mask that is in effect a hollow leak-free plug against the upper oesophageal sphincter, with a low-flow high-volume escape route above it. The device 1 of this embodiment of the invention enables a user to get such a plug into place and hold it there whilst providing a sufficiently generous escape path for emerging fluids. Further still, it has been found that the provision of a gastric inlet port that is angled dorsally as described further aids in ensuring that the seal around the upper oesophageal sphincter remains intact even under heavy load, particularly when an atrium is provided directly upstream therefrom.


Thus, it can be seen that the above described embodiments address the problems of prior art devices in novel and inventive ways.


Features of the above-described embodiments may be re-combined into further embodiments falling within the scope of the present invention. Further, the present invention is not limited to the exemplary materials and methods of construction outlined above in connection with the exemplary embodiments, and any suitable materials or methods of construction may be employed. For example, although the cuff may be formed using a sheet of soft flexible silicone rubber, other materials such as latex or PVC may be used. PVC as a material is particularly suited to embodiments intended for single use, whereas the use of silicone rubber is preferred although not essential for embodiments intended to be re-used in a number of medical procedures.


Further, and as would be appreciated by the skilled person, various features of the present invention are applicable to a wide range of different laryngeal mask airway devices, and the invention is not limited to the exemplary embodiments of types of mask described above. For example, aspects of the invention may be applied to laryngeal mask airway devices featuring epiglotic elevator bars over the mask aperture, which bars are operable to lift the epiglottis of a patient away from the aperture upon insertion of an endotracheal tube or other longitudinally-extended element inserted through the airway tube so as to emerge into the hollow or lumen of the mask through the mask aperture. Aspects of the present invention may for example be applied to single or re-useable devices, devices featuring aperture bars or not, “intubating” devices which permit an endotracheal tube or similar to be introduced into the larynx via an airway tube of a mask, devices incorporating fiberoptic viewing devices and so forth, without restriction or limitation on the scope of the present invention.

Claims
  • 1. An artificial airway device to facilitate lung ventilation of a patient, comprising an airway tube, a gastric drain tube and a mask at one end of the airway tube, the mask including a backplate and having a peripheral formation adapted to form a seal around the circumference of the laryngeal inlet when the device is in situ, the peripheral formation surrounding a hollow interior space in the form of a lumen of the mask and the airway tube opening into the lumen of the mask, wherein the mask includes an atrium for passage to the drain tube of gastric matter leaving the oesophagus when the device is in situ, wherein the atrium is defined by a wall of the backplate, wherein the wall comprises an outer skin and an inner skin, the outer skin comprising part of the gastric drain tube, the inner skin comprising a part of the airway tube.
  • 2. A device according to claim 1, wherein the atrium is formed between the inner and outer skins.
  • 3. A device according to claim 1, the inner skin including an inlet to the atrium.
  • 4. A device according to claim 1, wherein the inner and outer skins are formed from a resiliently deformable material that is softer in durometer than the material of the airway tube.
  • 5. A device according to claim 1, wherein the airway tube is disposed within the gastric drain tube.
  • 6. A device according to claim 5, the part of the gastric drain tube being an integrally formed part thereof.
  • 7. A device according to claim 5, the said part of the airway tube comprising a bore in fluid communication with the lumen of the mask.
  • 8. A device according to claim 5, wherein the gastric drain tube has an interior space and wherein the airway tube establishes a separation of the interior space within the gastric drain tube into two gastric conduits.
  • 9. A device according to claim 5, wherein the gastric drain tube comprises an expansible material.
  • 10. A device according to claim 1, wherein the backplate wall outer skin comprises a transparent or translucent material to allow for a visual inspection of the device's contents when the device is removed from the patient.
  • 11. A device according to claim 10, wherein the outer skin comprises a transparent material.
Priority Claims (2)
Number Date Country Kind
1017453.0 Oct 2010 GB national
1115156.4 Sep 2011 GB national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/GB2011/001453 10/6/2011 WO 00 6/24/2013
Publishing Document Publishing Date Country Kind
WO2012/049448 4/19/2012 WO A
US Referenced Citations (239)
Number Name Date Kind
2099127 Leech Nov 1937 A
2839788 Dembiak Jun 1958 A
2862498 Weekes Dec 1958 A
3529596 Garner Sep 1970 A
3554673 Schwartz et al. Jan 1971 A
3576187 Oddera Apr 1971 A
3683908 Michael et al. Aug 1972 A
3794036 Carroll Feb 1974 A
3931822 Marici Jan 1976 A
3948273 Sanders Apr 1976 A
4056104 Jaffe Nov 1977 A
4067329 Winicki et al. Jan 1978 A
4104357 Blair Aug 1978 A
4116201 Shah Sep 1978 A
4134407 Elam Jan 1979 A
4159722 Walker Jul 1979 A
4166467 Abramson Sep 1979 A
4178938 Au et al. Dec 1979 A
4178940 Au et al. Dec 1979 A
4231365 Scarberry Nov 1980 A
4256099 Dryden Mar 1981 A
4285340 Gezari et al. Aug 1981 A
4351330 Scarberry Sep 1982 A
4363320 Kossove Dec 1982 A
4446864 Watson et al. May 1984 A
4471775 Clair et al. Sep 1984 A
4501273 McGinnis Feb 1985 A
4509514 Brain et al. Apr 1985 A
4510273 Miura et al. Apr 1985 A
4526196 Pistillo Jul 1985 A
4553540 Straith Nov 1985 A
4583917 Shah Apr 1986 A
4630606 Weerda et al. Dec 1986 A
4689041 Corday et al. Aug 1987 A
4700700 Eliachar Oct 1987 A
4770170 Sato et al. Sep 1988 A
4793327 Frankel Dec 1988 A
4798597 Vaillancourt Jan 1989 A
4825862 Sato et al. May 1989 A
4832020 Auqustine May 1989 A
4850349 Farahany Jul 1989 A
4856510 Kowalewski et al. Aug 1989 A
4872483 Shah Oct 1989 A
4896667 Magnusson et al. Jan 1990 A
4924862 Levinson May 1990 A
4953547 Poole, Jr. Sep 1990 A
4972963 Guarriello et al. Nov 1990 A
4981470 Bombeck, IV Jan 1991 A
4995388 Brain et al. Feb 1991 A
5038766 Parker Aug 1991 A
5042469 Augustine Aug 1991 A
5042476 Smith Aug 1991 A
5060647 Alessi Oct 1991 A
5067496 Eisele Nov 1991 A
5113875 Bennett May 1992 A
5174283 Parker Dec 1992 A
5203320 Augustine Apr 1993 A
5218970 Turnbull et al. Jun 1993 A
5235973 Levinson Aug 1993 A
5241325 Nguyen et al. Aug 1993 A
5241956 Brain et al. Sep 1993 A
5249571 Brain et al. Oct 1993 A
5273537 Haskvitz et al. Dec 1993 A
5277178 DinQiey et al. Jan 1994 A
5282464 Brain et al. Feb 1994 A
5297547 Brain et al. Mar 1994 A
5303697 Brain et al. Apr 1994 A
5305743 Brain Apr 1994 A
5311861 Miller et al. May 1994 A
5318017 Ellison Jun 1994 A
5331967 Akerson et al. Jul 1994 A
5339805 Parker Aug 1994 A
5339808 Don Michael Aug 1994 A
5355879 Brain et al. Oct 1994 A
5361753 Pothmann et al. Nov 1994 A
5391248 Brain et al. Feb 1995 A
5400771 Pirak et al. Mar 1995 A
5421325 Cinberg et al. Jun 1995 A
5438982 Macintyre Aug 1995 A
5443063 Greenberg Aug 1995 A
5452715 Boussignac et al. Sep 1995 A
5459700 Jacobs Oct 1995 A
5487383 Levinson Jan 1996 A
5529582 Fukuhara et al. Jun 1996 A
5546935 Champeau Aug 1996 A
5546936 Virag et al. Aug 1996 A
5551420 Lurie et al. Sep 1996 A
5554673 Shah Sep 1996 A
5569219 Hakki et al. Oct 1996 A
5577693 Corn Nov 1996 A
5582167 Joseph Dec 1996 A
5584290 Brain et al. Dec 1996 A
5590643 Flam Jan 1997 A
5599301 Jacobs et al. Feb 1997 A
5623921 Kinsinger et al. Apr 1997 A
5626151 Linden May 1997 A
5632271 Brain et al. May 1997 A
RE35531 Callaghan et al. Jun 1997 E
5653229 Greenberg Aug 1997 A
5655528 Paqan et al. Aug 1997 A
5682880 Brain et al. Nov 1997 A
5692498 Lurie et al. Dec 1997 A
5694929 Christopher Dec 1997 A
5711293 Brain et al. Jan 1998 A
5738094 Hottman Apr 1998 A
5743254 Parker Apr 1998 A
5743258 Sato et al. Apr 1998 A
5746202 Paqan et al. May 1998 A
5771889 Pagan et al. Jun 1998 A
5778872 Fukunaga et al. Jul 1998 A
5791341 Bullard Aug 1998 A
5794617 Brunell et al. Aug 1998 A
5816240 Komesaroff Oct 1998 A
5819723 Joseph Oct 1998 A
5832916 Lundberg et al. Nov 1998 A
5850832 Chu Dec 1998 A
5855203 Matter Jan 1999 A
5856510 Meng et al. Jan 1999 A
5860418 Lundberg et al. Jan 1999 A
5862801 Wells Jan 1999 A
5865176 O'Neil et al. Feb 1999 A
5878745 Brain et al. Mar 1999 A
5881726 Neame Mar 1999 A
5893891 Zahedi et al. Apr 1999 A
5896858 Brain Apr 1999 A
5915383 Pagan Jun 1999 A
5921239 McCall et al. Jul 1999 A
5924862 White Jul 1999 A
5937860 Cook Aug 1999 A
5957133 Hart Sep 1999 A
5976075 Beane et al. Nov 1999 A
5979445 Neame et al. Nov 1999 A
5983891 Fukunaga Nov 1999 A
5983896 Fukunaqa et al. Nov 1999 A
5983897 Pagan Nov 1999 A
5988167 Kamen Nov 1999 A
5996582 Turnbull Dec 1999 A
6003510 Anunta Dec 1999 A
6003511 Fukunaga et al. Dec 1999 A
6003514 Pagan Dec 1999 A
6012452 Pagan Jan 2000 A
6021779 Paqan Feb 2000 A
6050264 Greenfield Apr 2000 A
6062219 Lurie et al. May 2000 A
6070581 Augustine et al. Jun 2000 A
6079409 Brain et al. Jun 2000 A
D429811 Bermudez et al. Aug 2000 S
6095144 Pagan Aug 2000 A
6098621 Esnouf et al. Aug 2000 A
6110143 Kamen Aug 2000 A
6116243 Pagan Sep 2000 A
6119695 Augustine et al. Sep 2000 A
6131571 Lamootang et al. Oct 2000 A
6149603 Parker Nov 2000 A
6155257 Lurie et al. Dec 2000 A
6213120 Block et al. Apr 2001 B1
6224562 Lurie et al. May 2001 B1
6234985 Lurie et al. May 2001 B1
6240922 Pagan Jun 2001 B1
6251093 Valley et al. Jun 2001 B1
6269813 Fitzgerald et al. Aug 2001 B1
6315739 Merilainen et al. Nov 2001 B1
6338343 Augustine et al. Jan 2002 B1
6352077 Shah Mar 2002 B1
6386199 Alfery May 2002 B1
6390093 Mongeon May 2002 B1
6422239 Cook Jul 2002 B1
6427686 Augustine et al. Aug 2002 B2
6439232 Brain Aug 2002 B1
6450164 Banner et al. Sep 2002 B1
6508250 Esnouf Jan 2003 B1
6546931 Lin et al. Apr 2003 B2
6631720 Brain et al. Oct 2003 B1
6647984 O'Dea et al. Nov 2003 B1
6651666 Owens Nov 2003 B1
6705318 Brain Mar 2004 B1
6766801 Wright Jul 2004 B1
6955645 Zeitels Oct 2005 B1
7004169 Brain et al. Feb 2006 B2
7040322 Fortuna et al. May 2006 B2
7051096 Krawiec et al. May 2006 B1
7051736 Banner et al. May 2006 B2
7096868 Tateo et al. Aug 2006 B2
7097802 Brain et al. Aug 2006 B2
7128071 Brain et al. Oct 2006 B2
7134431 Brain et al. Nov 2006 B2
7156100 Brain et al. Jan 2007 B1
7159589 Brain Jan 2007 B2
RE39938 Brain Dec 2007 E
7383736 Esnouf Jun 2008 B2
7694682 Petersen et al. Apr 2010 B2
7997274 Baska Aug 2011 B2
8033176 Esnouf Oct 2011 B2
8413658 Williams Apr 2013 B2
20030000534 Alfery Jan 2003 A1
20030037790 Brain Feb 2003 A1
20030051734 Brain Mar 2003 A1
20030101998 Zecca et al. Jun 2003 A1
20030131845 Lin Jul 2003 A1
20030168062 Blythe et al. Sep 2003 A1
20030172925 Zecca et al. Sep 2003 A1
20030172935 Miller Sep 2003 A1
20040020491 Fortuna Feb 2004 A1
20040089307 Brain May 2004 A1
20050066975 Brain Mar 2005 A1
20050081861 Nasir Apr 2005 A1
20050090712 Cubb Apr 2005 A1
20050133037 Russell Jun 2005 A1
20050139220 Christopher Jun 2005 A1
20050178388 Kuo Aug 2005 A1
20050199244 Tateo et al. Sep 2005 A1
20050274383 Brain Dec 2005 A1
20060124132 Brain Jun 2006 A1
20060180156 Baska Aug 2006 A1
20060201516 Petersen et al. Sep 2006 A1
20060254596 Brain Nov 2006 A1
20070089754 Jones Apr 2007 A1
20070240722 Kessler Oct 2007 A1
20080041392 Cook Feb 2008 A1
20080142017 Brain Jun 2008 A1
20080276936 Cook Nov 2008 A1
20080308109 Brain Dec 2008 A1
20090090356 Cook Apr 2009 A1
20090133701 Brain May 2009 A1
20090139524 Esnouf Jun 2009 A1
20090145438 Brain Jun 2009 A1
20100059061 Brain Mar 2010 A1
20100089393 Brain Apr 2010 A1
20100211140 Barbut et al. Aug 2010 A1
20100242957 Fortuna Sep 2010 A1
20110023890 Baska Feb 2011 A1
20110220117 Dubach Sep 2011 A1
20120085351 Brain Apr 2012 A1
20120090609 Dubach Apr 2012 A1
20120145161 Brain Jun 2012 A1
20120174929 Esnouf Jul 2012 A1
20120186510 Esnouf Jul 2012 A1
20140034060 Esnouf et al. Feb 2014 A1
20150209538 Hansen Jul 2015 A1
Foreign Referenced Citations (93)
Number Date Country
647437 Jun 1991 AU
2067782 Nov 1989 CA
2141167 Jan 1994 CA
2012750 Aug 1999 CA
4447186 Jul 1996 DE
10042172 Apr 2001 DE
0294200 Dec 1988 EP
0294200 Dec 1988 EP
0389272 Sep 1990 EP
0402872 Dec 1990 EP
0580385 Jan 1994 EP
0712638 May 1996 EP
0732116 Sep 1996 EP
0796631 Sep 1997 EP
0842672 May 1998 EP
0845276 Jun 1998 EP
0865798 Sep 1998 EP
0922465 Jun 1999 EP
0935971 Aug 1999 EP
1119386 Aug 2001 EP
1125595 Aug 2001 EP
1 938 855 Jul 2008 EP
2 044 969 Apr 2009 EP
1529190 Oct 1978 GB
2111394 Jul 1983 GB
2205499 Dec 1988 GB
2 298 580 Sep 1996 GB
2298797 Sep 1996 GB
2317342 Mar 1998 GB
2317830 Apr 1998 GB
2318735 May 1998 GB
2319478 May 1998 GB
2321854 Aug 1998 GB
2323289 Sep 1998 GB
2323290 Sep 1998 GB
2323291 Sep 1998 GB
2323292 Sep 1998 GB
2324737 Nov 1998 GB
2334215 Aug 1999 GB
2359996 Sep 2001 GB
2371990 Aug 2002 GB
2 404 863 Feb 2005 GB
2405588 Mar 2005 GB
2 444 779 Jun 2008 GB
2 465 453 May 2010 GB
03039169 Feb 1991 JP
10118182 May 1998 JP
10216233 Aug 1998 JP
10263086 Oct 1998 JP
10277156 Oct 1998 JP
10314308 Dec 1998 JP
10323391 Dec 1998 JP
10328303 Dec 1998 JP
11128349 May 1999 JP
11192304 Jul 1999 JP
11206885 Aug 1999 JP
2000152995 Jun 2000 JP
2003528701 Sep 2003 JP
WO9103207 Mar 1991 WO
WO9107201 May 1991 WO
WO9112845 Sep 1991 WO
WO9213587 Aug 1992 WO
WO 9402191 Feb 1994 WO
WO9402191 Feb 1994 WO
WO9533506 Dec 1995 WO
WO9712640 Apr 1997 WO
WO9712641 Apr 1997 WO
WO9816273 Apr 1998 WO
WO9850096 Nov 1998 WO
WO9906093 Feb 1999 WO
WO 9927840 Jun 1999 WO
WO0009189 Feb 2000 WO
WO0022985 Apr 2000 WO
WO0023135 Apr 2000 WO
WO0061212 Oct 2000 WO
WO0124860 Apr 2001 WO
WO0174431 Oct 2001 WO
WO0232490 Apr 2002 WO
WO 2004016308 Feb 2004 WO
WO2004030527 Apr 2004 WO
WO 2004089453 Oct 2004 WO
WO 2005011784 Feb 2005 WO
WO2005011784 Feb 2005 WO
WO2005023350 Mar 2005 WO
WO 2005046751 May 2005 WO
WO2006026237 Mar 2006 WO
WO2006125989 Nov 2006 WO
WO 2007071429 Oct 2007 WO
WO 2008001724 Jan 2008 WO
WO 2009026628 Mar 2009 WO
WO 2010060227 Jun 2010 WO
WO 2010066001 Jun 2010 WO
WO 2010060226 Jun 2010 WO
Non-Patent Literature Citations (57)
Entry
International Search Report for PCT/GB2006/001913, mailed Aug. 28, 2006.
M.O. Abdelatti; “A Cuff Pressure Controller for Tracheal Tubes and Laryngeal Mask Airways” Anaesthesia, 1999, 54, pp. 981-986 (1999 Blackwell Science Ltd).
Jonathan L. Benumo, M.D.; “Laryngeal Mask Airway and the ASA Difficult Airway Algorithm” Medical Intelligence Article; Anesthesiology, V 84, No. 3, Mar. 1996 (686-99).
Jonathan L. Benumo, M.D.; “Management of the Difficult Adult Airway” With Special Emphasis on Awake Tracheal Intubation; Anesthesiology V 75, No. 6: 1087-1110, 1991.
Bernhard, et al.; “Adjustment of Intracuff Pressure to Prevent Aspiration” ; Anesthesiology, vol. 50, No. 4, 363-366, Apr. 1979.
Bernhard, et al.; “Physical Characteristics of and Rates of Nitrous Oxide Diffusion into Tracheal Tube Cuffs” Anesthesiology, vol. 48, No. 6 Jun. 1978, 413-417.
A.I.J. Brain, et al.: “The Laryngeal Mask Airway” Anesthesia, 1985, vol. 40, pp. 356-361.
A.I.J. Brain, et al.: “The Laryngeal Mask Airway—A Possible New Solution to Airway Problems in the Emergency Situation” Archives of Emergency Medicine, 1984, vol. 1, p. 229-232.
A.I.J. Brain; “The Laryngeal Mask—A New Concept in Airway Management” British Journal of Anaesthesia, 1983, vol. 55, p. 801-805.
A.I.J. Brain, et al.: “A New Laryngeal Mask Prototype” Anaesthesia, 1995, vol. 50, pp. 42-48.
A.I.J. Brain; “Three Cases of Difficult Intubation Overcome by the Laryngeal Mask Airway” ; Anaesthesia, 1985, vol. 40, pp. 353-355.
J. Brimacombe; “The Split Laryngeal Mask Airway” ; Royal Perth Hospital, Perth 6001 Western Australia; Correspondence p. 639.
P.M. Brodrick et al.; “The Laryngeal Mask Airway” ; Anaesthesia, 1989, vol. 44, pp. 238-241; The Association of Anaesthetists of Gt Britain and Ireland.
Burgard et al.; “The Effect of Laryngeal Mask Cuff Pressure on Postoperative Sore Throat Incidence” ; Journal of Clinical Anesthesia 8: 198-201, 1996 by Elsevier Science Inc.
Caplan, et al.; “Adverse Respiratory Events in Anesthesia: A Closed Claims Analysis”; Anesthesiology vol. 72, No. 5: 828-833, May 1990.
Donald E. Craven, MD; “Prevention of Hospital-Acquired Pneumonia: Meaning Effect in Ounces, Pounds, and Tons”; Annals of Internal Medicine, vol. 122, No. 3, Feb. 1, 1995, pp. 229-231.
“Cuff-Pressure-Control CDR 2000”; LogoMed, Klarenplatz 11, D-53578 Windhagen, pp. 1-4.
P.R.F. Davies et al.; “Laryngeal Mask Airway and Tracheal Tube Insertion by Unskilled Personnel”; The Lancet, vol. 336, p. 977-979.
DeMello et al.; “The Use of the Laryngeal Mask Airway in Primary Anaesthesia” Cambridge Military Hospital, Aldershot, Hants GU11 2AN; pp. 793-794.
Doyle et al.; “Intraoperative Awareness: A Continuing Clinical Problem”; Educational Synopses in Anesthesiology and Critical Care Medicine The Online Journal of Anesthesiology vol. 3 No. 6 Jun. 1996, pp. 1-8.
F. Engbers; “Practical Use of ‘Diprifusor’ Systems”; Anaesthesia, 1998, vol. 53, Supplement 1, pp. 28-34; Blackwell Science Ltd.
Eriksson et al.; “Functional Assessment of the Pharynx at Rest and During Swallowing in Partially Paralyzed Humans” Anesthesiology, vol. 87, No. 5, Nov. 1997, pp. 1035-1042.
J.B. Glen; “The Development of ‘Diprifusor’: A TCI System for Propofol” Anaesthesia, 1998, vol. 53, Supplement 1, pp. 13-21, Blackwell Science Ltd.
J.M. Gray et al.; “Development of the Technology for ‘Diprifusor’ TCI Systems”; Anaesthesia, 1998, vol. 53, Supplement 1, pp. 22-27, Blackwell Science Ltd.
M.L. Heath; “Endotracheal Intubation Through the Laryngeal Mask—Helpful When Laryngoscopy is Difficult or Dangerous”; European Journal of Anaesthesiology 1991, Supplement 4, pp. 41-45.
S. Hickey et al.; “Cardiovascular Response to Insertion of Brian's Laryngeal Mask”; Anaesthesia, 1990, vol. 45, pp. 629-633, The Association of Anaesthetists of Gt Britain and Ireland.
Inomata et al.; “Transient Bilateral Vocal Cord Paralysis after Insertion of a Laryngeal Mask Airway”; Anaesthesiology, vol. 82, No. 3, Mar. 1995, pp. 787-788.
L. Jacobson et al.; “A Study of Intracuff Pressure Measurements, Trends and Behaviour in Patients During Prolonged Periods of Tracheal Intubation” British Journal of Anaesthesia (1981), vol. 53, pp. 97-101; Macmillan Publishers Ltd. 1981.
V. Kambic et al.; “Intubation Lesions of the Larynx”; British Journal of Anaesthesia (1978), vol. 50, pp. 587-590; Macmillan Journals Ltd. 1978.
A.Kapila et al.; “Intubating Laryngeal Mask Airway: A Preliminary Assessment of Performance”; British Journal of Anaesthesia 1995, vol. 75: pp. 228-229.
Carl-Eric Lindholm; “Prolonged Endotracheal Intubation” ; Iussu Societatis Anaesthesiologicae Scandinavica Edita Suppllementum XXXIII 1969 v. 33 pp. 29-46.
S. Majumder et al.; “Bilateral Lingual Nerve Injury Following the Use of the Laryngeal Mask Airway” ; Anaesthesia, 1998, vol. 53, pp. 184-186, 1998 Blackwell Science Ltd.
Todd Martin; “Patentability of Methods of Medical Treatment: A Comparative Study”; HeinOnLine—82 J. Pat. & Trademark Off. Soc'y 2000, pp. 381-423.
Merriam-Webster's Collegiate Dictionary Tenth Edition, Springfield, Mass, U.S.A. (Convex) p. 254 & (Saddle) p. 1029.
D.M. Miller; “A Pressure Regulator for the Cuff of a Tracheal Tube” Anaesthesia, 1992, vol. 47, pp. 594-596; 1992 The Association of Anaesthetists of Gt Britain and Ireland.
Muthuswamy et al.; “The Use of Fuzzy Integrals and Bispectral Analysis of the Electroencephalogram to Preddict Movement Under Anesthesia”; Ieee Transactions on Biomedical Engineering, vol. 46, No. 3, Mar. 1999, pp. 291-299.
K. Nagai et al.; “Unilateral Hypoglossal Nerve Paralysis Following the Use of the Laryngeal Mask Airway”; Anaesthesia, 1994, vol. 49, pp. 603-604; 1994 The Association of Anaesthetists of Gt Britain and Ireland.
Lars J. Kangas; “Neurometric Assessment of Adequacy of Intraoperative Anesthetic” Medical Technology Brief, Pacific Northwest National Laboratory, pp. 1-3.
Observations by a third party concerning the European Patent Application No. 99947765.6-2318, dated Jan. 18, 2005.
R.I. Patel et al.; “Tracheal Tube Cuff Pressure”; Anaesthesia, 1984, vol. 39, pp. 862-864; 1984 The Association of Anaesthetists of Gt Britain and Ireland.
Written Opinion of the International Searching Authority for Application No. PCT/GB2006/001913.
Pennant et al.; “Comparison of the Endotracheal Tube and Laryngeal Mask in Airway Management by Paramedical Personnel”; Dept of Anesthesiology, University of Texas Southwestern Medical School; Anesth Analg 1992, vol. 74, pp. 531-534.
Pippin et al.; “Long-Term Tracheal Intubation Practice in the United Kingdom”; Anaesthesia, 1983, vol. 38, pp. 791-795.
J.C. Raeder et al.; “Tracheal Tube Cuff Pressures” Anaesthesia, 1985, vol. 40, pp. 444-447; 1985 The Association of Anaesthetists of Gt Britain and Ireland.
Response to Complaint for matter No. 4b 0 440-05, LMA Deutschland GmbH vs. Ambu (Deutschland) GmbH, dated Feb. 10, 2006.
Rieger et al.; “Intracuff Pressures Do Not Predict Laryngopharyngeal Discomfort after Use of the Laryngeal Mask Airway”; Anesthesiology 1997, vol. 87, pp. 63-67; 1997 American Society of Anesthesiologists, Inc.
R D Seegobin et al.; “Endotracheal Cuff Pressure and Tracheal Mucosal Blood Flow: Endoscopic Study of Effects of Four Large Volume Cuffs”; British Medical Jornal, vol. 288, Mar. 31, 1984, pp. 965-968.
B.A. Willis et al.; “Tracheal Tube Cuff Pressure” Anaesthesia, 1988, vol. 43, pp. 312-314; The Asociation of Anaesthetists of Gt Britain and Ireland.
L. Worthington et al.; “Performance of Vaporizers in Circle Systems” British Journal of Anaesthesia 1995, vol. 75.
J. Michael Wynn, M.D.; “Tongue Cyanosis after Laryngeal Mask Airway Insertion” Anesthesiology, vol. 80, No. 6, Jun. 1994, p. 1403.
Brimacombe, Joseph R., “Laryngeal Mask Anesthesia” Second Edition, Saunders 2005.
“Anaesthetic and respiratory equipment—Supralaryngeal airways and connectors”, International Standard Controlled, ISO 11712, ISO 2009.
Miller, Donald, “A Proposed Classification and Scoring System for Supraglottic Sealing Airways: A Brief Review”, Anesth Analg 2004; 99:1553-9.
Benumof, Jonathan, “The Glottic Aperture Seal Airway. A New Ventilatory Device”, Anesthesiology, V. 88, No. 5., May 1998, pp. 1219-1226.
McIntyre, John, “History of Anaesthesia” Oropharyngeal and nasopharyngeal airways: I (1880-1995), Can. J. Anaesth 1996, vol. 43, vol. 6, pp. 629-635.
Ishimura, et al., “Impossible Insertion of the Laryngeal Mask Airway and Oropharyngeal Axes”, Anesthesiology, V. 83, No. 4., Oct. 1995, pp. 867-869.
Verghese, et al., “Clinical assessment of the single use laryngeal mask airway—the LMA-Unique”, British Journal of Anaesthesia 1998; vol. 80: 677-679.
Related Publications (1)
Number Date Country
20130269689 A1 Oct 2013 US